PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
226.57%
Net income growth at 50-75% of BTE's 431.90%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-48.89%
Negative yoy D&A while BTE is 10.66%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
1240.68%
Some yoy growth while BTE is negative at -113.84%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
98.30%
Less working capital growth vs. BTE's 214.24%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Growth well above BTE's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-23.02%
Both negative yoy, with BTE at -650.53%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
21.05%
Operating cash flow growth above 1.5x BTE's 7.85%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
18.58%
Some CapEx rise while BTE is negative at -485.94%. John Neff would see competitor possibly building capacity while we hold back expansions.
-155.78%
Negative yoy acquisition while BTE stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
168.74%
Purchases growth of 168.74% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-162.53%
We reduce yoy sales while BTE is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-157.56%
We reduce yoy other investing while BTE is 118.90%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
365.10%
Investing outflow well above BTE's 24.73%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
17.77%
Debt repayment growth of 17.77% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
227.31%
Issuance growth of 227.31% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-186831.83%
We cut yoy buybacks while BTE is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.